Achmea Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,951
Closed -$3.28M 113
2025
Q4
$3.28M Hold
39,951
0.08% 98
2025
Q3
$3M Hold
39,951
0.04% 235
2025
Q2
$2.96M Hold
39,951
0.04% 246
2025
Q1
$3.22M Buy
39,951
+13,155
+49% +$1.13M 0.05% 247
2024
Q4
$2.1M Buy
26,796
+7,596
+40% +$646K 0.03% 289
2024
Q3
$1.8M Hold
19,200
0.03% 308
2024
Q2
$1.5M Sell
19,200
-85,487
-82% -$6.97M 0.03% 326
2024
Q1
$9.52M Sell
104,687
-2,973
-3% -$247K 0.18% 141
2023
Q4
$8.32M Sell
107,660
-35,719
-25% -$2.5M 0.17% 150
2023
Q3
$9.76M Sell
143,379
-7,077
-5% -$515K 0.21% 116
2023
Q2
$12.2M Buy
150,456
+54,573
+57% +$4.35M 0.26% 99
2023
Q1
$7.87M Buy
+95,883
New +$6.85M 0.23% 118

Other funds holding GEHC

Achmea Investment Management's GEHC Position: Q1 2026 in Review

Achmea Investment Management sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 39,951 shares — an estimated $3.28M sold.

Achmea Investment Management first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $12.2M in Q2 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Achmea Investment Management reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Achmea Investment Management sold 39,951 GE HealthCare shares in Q1 2026, an estimated $3.28M.
  • Achmea Investment Management first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
  • Achmea Investment Management's GE HealthCare position peaked at $12.2M in Q2 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Achmea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.